INVARIANT LLC

Lobbying for EGENESIS INC. · Gene editing platform for the development of transplantable organs.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $110,000.00 income · posted Jul 17, 2025

Lobbying activity 1

Health Issues

Educate lawmakers and policymakers on xenotransplantation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.